Skip to content

Checked

Class IIDrug recallOngoing

Med Pride, HYDROCORTISONE CREAM 1% recall

Recalled by Dabur India Limited of Dadra And Nagar Haveli, India · FDA report 06/24/2026

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Ongoing
Recall started
06/02/2026
Distribution
Nationwide

Reason for recall

CGMP Deviations; deficiencies observed during FDA inspection

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Med Pride, HYDROCORTISONE CREAM 1%, Net Wt. 16oz (454g) tubes, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 305061.
Lot and code info
Lot# 003, 004, 005, 006, 007, 008, 009, 010, 011, 012, 014, 015, 017, 018, 019, 020, 021, 022, 023, 024, 025, 026, 027, 028, 029, 030, 034, 035, 036, 037, 038, 039, 041, 042, 043, 044, 048, 049, 050, 051, 052, 053, 054, 055, 056, 057, 058, 059, 060, 061, 062, 063, 064, Within Expiry.
Quantity
4,738 tubes
Recall number
D-0639-2026
Event ID
99137
Initiated by
Voluntary: Firm initiated

Where it was distributed

US Nationwide.

  • Nationwide

Recall timeline

  1. 06/02/2026Firm started the recall
  2. 06/24/2026Published in the FDA enforcement report
  3. 06/26/2026FDA classified it as Class II

All products in this recall

14 products under event 99137

Frequently asked questions

Why was Med Pride, HYDROCORTISONE CREAM 1% recalled?
CGMP Deviations; deficiencies observed during FDA inspection
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
US Nationwide.
Is this recall still active?
The FDA lists the recall as ongoing. The recall is still in progress.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 06/24/2026 · Do not rely on openFDA to make decisions regarding medical care